Feature | May 14, 2014

Study Shows Significant Overall Cost Savings Using Quadripolar System

Comparative effectiveness study shows use of quadripolar technology reduces hospital utilization and lowers overall costs

May 14, 2014 — Data presented during Heart Rhythm 2014 found the use of quadripolar leads reduced the number of hospitalizations by 53 percent when compared to the non-quadripolar group. This hospitalization rate reduction translated into a statistically significant 62 percent reduction in overall costs for both healthcare systems and patients.

The “Hospitalization Rates and Associated Cost Analysis of Quadripolar versus Bipolar CRT-D: a comparative analysis of a single-center prospective Italian registry” presentation included data that demonstrated hospitalization rates for the quadripolar group were lower than the non-quadripolar group, and patients with the St. Jude Medical Quartet quadripolar LV (left ventricular) lead had a 98 percent probability of having lower costs than patients with non-quadripolar leads. The study showed that use of the quadripolar LV lead was associated with significantly reduced hospitalizations specific to the two types of hospitalizations studied: heart failure and LV lead surgical revision.

“These data are compelling evidence as they show a significant cost saving for the healthcare system and patients utilizing the St. Jude Medical quadripolar pacing system,” said Giovanni Forleo, M.D., electrophysiologist at the University Hospital of Tor Vergata in Rome. “This study showed a strong cost benefit, further demonstrating why quadripolar technology is becoming the standard-of-care for patients requiring CRT [cardiac resynchronization therapy].”

The prospective, single-center, observational registry was a first-time evaluation of hospitalization rates and cost reduction following CRT with quadripolar versus non-quadripolar LV leads. Over three years, 198 patients implanted with either a St. Jude Medical Quartet quadripolar LV lead or a non-quadripolar LV lead, were enrolled in the study. The goal of the study was to compare the hospitalization rate related to heart failure and LV lead surgical revisions between the Quartet quadripolar lead and a traditional bipolar lead for cardiac resynchronization therapy defibrillators (CRT-Ds).

“This study provides additional evidence that the quadripolar system improves patient outcomes and reduces healthcare costs,” said Mark D. Carlson, M.D., chief medical officer and vice president of global clinical affairs for St. Jude Medical. “This study is another example of St. Jude Medical’s commitment to investing in disruptive technologies that transform the treatment of expensive epidemic diseases.”

For more information: www.sjm.com

Related Content

Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

News | EP Mapping and Imaging Systems| October 06, 2015
Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging...
News | Business| October 06, 2015
GE Healthcare announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop...
News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
AtriCure, cryoFORM cryoablation probe, launch
Technology | Ablation Systems| October 02, 2015
AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety...
predicting arrhythmias, mcgill university, alternans patterns
News | EP Lab| September 28, 2015
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a...
ACC, atrial fibrillation registries, ablation, left atrial appendage occlusion procedures, LAAO Registry
News | Atrial Fibrillation| September 24, 2015
The American College of Cardiology (ACC) launched two new clinical registry programs in August to track real-world...
Biotronik, NORDIC ICD trial, defibrillation testing, DF testing, shock efficacy
News | Implantable Cardioverter Defibrillators (ICD)| September 24, 2015
Biotronik announced the publication of NORDIC ICD (NO Regular Defibrillation testing In Cardioverter-Defibrillator...
guideline, treating supraventricular tachycardia, ACC, AHA, HRS
News | EP Lab| September 23, 2015
A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate,...
ONC, Federal Health IT Strategic Plan 2015-2020, information technology, healthcare
Feature | Information Technology| September 22, 2015
The U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology...
MedLumics, OCT, real-time assessment, catheter ablation, atrial fibrillation
Feature | EP Mapping and Imaging Systems| September 17, 2015
MedLumics has announced the completion of a successful single-case pre-clinical feasibility study of its optical...
Overlay Init